Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

CAS No. :	484-20-8
Formula :	C₁₂H₈O₄
M.W :	216.19
SMILES Code :	O=C1C=CC2=C(O1)C=C(OC=C3)C3=C2OC
Synonyms :	5-Methoxypsoralen; 5-MOP; NSC 95437
MDL No. :	MFCD00010272
InChI Key :	BGEBZHIAGXMEMV-UHFFFAOYSA-N
Pubchem ID :	2355

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302-H315-H319-H335-H351-H361
Precautionary Statements:	P261-P305+P351+P338

SW620	354.5 µM (IC50)	96 hours	Inhibited cell proliferation	Int J Mol Sci. 2023 Oct 25;24(21):15555.
HT-29	332.4 µM (IC50)	96 hours	Inhibited cell proliferation	Int J Mol Sci. 2023 Oct 25;24(21):15555.
HOS	257.5 µM (IC50)	96 hours	Inhibited cell proliferation	Int J Mol Sci. 2023 Oct 25;24(21):15555.
Saos-2	40.05 µM (IC50)	96 hours	Inhibited cell proliferation, induced apoptosis	Int J Mol Sci. 2023 Oct 25;24(21):15555.
RPMI8226	1272 µM (IC50)	96 hours	Inhibited cell proliferation	Int J Mol Sci. 2023 Oct 25;24(21):15555.
HFOB	200-400 µM	48 hours	To evaluate cytotoxicity	Int J Mol Sci. 2023 Oct 25;24(21):15555.
HSF	200-400 µM	48 hours	To evaluate cytotoxicity	Int J Mol Sci. 2023 Oct 25;24(21):15555.
U266	1190 µM (IC50)	96 hours	Inhibited cell proliferation	Int J Mol Sci. 2023 Oct 25;24(21):15555.
HUVEC cells	2.5-40 µM	12 or 24 hours	To evaluate the biocompatibility of Ber-lipo, results showed that Ber-lipo had good biocompatibility and Lipo significantly reduced the cytotoxicity of bergapten.	Bioact Mater. 2024 Oct 1;43:406-422.
RAW264.7 cells	2.5-40 µM	12 or 24 hours	To evaluate the biocompatibility of Ber-lipo, results showed that Ber-lipo had good biocompatibility and Lipo significantly reduced the cytotoxicity of bergapten.	Bioact Mater. 2024 Oct 1;43:406-422.
Bone marrow-derived macrophages (BMDMs)	20 µM	2 hours	Inhibited NLRP3 inflammasome activation, evidenced by attenuated cleaved caspase-1 and mature IL-1β release, as well as reduced ASC speck formation and subsequent gasdermin D (GSDMD)-mediated pyroptosis.	Acta Pharmacol Sin. 2023 Sep;44(9):1867-1878.
J774A.1 cells	20 µM	2 hours	Inhibited NLRP3 inflammasome activation, evidenced by attenuated cleaved caspase-1 and mature IL-1β release, as well as reduced ASC speck formation and subsequent gasdermin D (GSDMD)-mediated pyroptosis.	Acta Pharmacol Sin. 2023 Sep;44(9):1867-1878.
RAW264.7 macrophages	62.5, 125, 250 µM	24 hours	To evaluate the effect of Bergapten on NO and PGE2 production in RAW264.7 cells. Results showed that Bergapten significantly inhibited LPS-induced NO and PGE2 production.	Int J Mol Sci. 2022 May 22;23(10):5813.
Recombinant human CYP3A4 (rCYP3A4)	1.424 µM (IC50)	30 minutes	Bergapten significantly inhibited the metabolism of tofacitinib in recombinant human CYP3A4, showing competitive inhibition	corylifolia on the pharmacokinetic profile of tofacitinib and the underlying mechanism. Front Pharmacol.
Human liver microsomes (HLMs)	2.647 µM (IC50)	30 minutes	Bergapten significantly inhibited the metabolism of tofacitinib in human liver microsomes, showing competitive inhibition	corylifolia on the pharmacokinetic profile of tofacitinib and the underlying mechanism. Front Pharmacol.
Rat liver microsomes (RLMs)	2.619 µM (IC50)	30 minutes	Bergapten significantly inhibited the metabolism of tofacitinib in rat liver microsomes, showing competitive inhibition	corylifolia on the pharmacokinetic profile of tofacitinib and the underlying mechanism. Front Pharmacol.
B16F10 melanoma cells	6.25, 12.5, 25 µM	48 hours	To evaluate the effect of Bergapten on the expression of melanogenesis-related proteins, results showed that Bergapten significantly increased the protein expression levels of MITF, tyrosinase, TRP-1, and TRP-2.	Molecules. 2022 Apr 19;27(9):2613.
B16F10 melanoma cells	6.25, 12.5, 25 µM	48 hours	To evaluate the effect of Bergapten on the expression of melanogenesis-related proteins, results showed that Bergapten increased the expression of MITF, tyrosinase, TRP-1, and TRP-2.	Molecules. 2022 Apr 19;27(9):2613.
ZR-75	20 µM and 50 µM	6 to 16 hours	Bergapten induces autophagy by up-regulating PTEN expression, increasing Beclin1, PI3KIII, UVRAG, AMBRA expression and conversion of LC3-I to LC3-II	Mol Cancer. 2015 Jul 7;14:130.
MCF-7	20 µM and 50 µM	6 to 16 hours	Bergapten induces autophagy by up-regulating PTEN expression, increasing Beclin1, PI3KIII, UVRAG, AMBRA expression and conversion of LC3-I to LC3-II	Mol Cancer. 2015 Jul 7;14:130.
B16F10 melanoma cells	6.25, 12.5, 25 µM	72 hours	To evaluate the effect of Bergapten on melanogenesis, results showed that Bergapten significantly increased melanin content and tyrosinase activity.	Molecules. 2022 Apr 19;27(9):2613.
B16F10 melanoma cells	1, 10, or 100 µM		To evaluate the effect of Bergapten on melanin content and tyrosinase activity, results showed that Bergapten dose-dependently increased melanin content and tyrosinase activity in B16F10 cells	J Adv Res. 2019 Oct 10;21:57-64.
Rabbit jejunum	0.0026 mg/ml		Bergapten exhibited concentration-dependent relaxation of both spontaneous and K+-induced contractions, similar to the effect of papaverine	Front Pharmacol. 2022 Nov 16;13:1005154.

Mice	High-fat diet and streptozotocin-induced diabetic mice	Dietary supplementation	0.02% (w/w)	For 10 weeks	To evaluate whether bergapten and methoxsalen could prevent diabetes-induced osteoporosis and its underlying mechanism. Results showed that both bergapten and methoxsalen significantly reversed the decrease in serum osteocalcin, bone-alkaline phosphatase, and femur BMD, increased bone volume density and trabecular number, while decreasing the structure model index of femur tissue in diabetic mice. Additionally, these derivatives significantly reduced the number and formation of osteoclasts in diabetic bone tissue and downregulated the expression of osteoclast-related genes.	Int J Mol Sci. 2019 Mar 14;20(6):1298
C57BL/6 mice	Vitiligo model	Transdermal administration	1% (w/w)	Once daily for 12 days	To evaluate the effect of Bergapten on hair pigmentation in vitiligo model mice, results showed that Bergapten significantly improved hair pigmentation	J Adv Res. 2019 Oct 10;21:57-64.
C57/B6 mice	High-fat diet-induced diabetes-related osteoporosis model	Oral	10 mg/kg/day and 20 mg/kg/day	Once daily for 20 weeks	Bergapten significantly inhibited RANKL-RANK signaling transduction, and suppressed the activation of the PI3K/AKT, JNK/MAPK and NF-κB signaling pathways, thus protecting trabecular structure and decreasing osteoclastogenic differentiation	Int J Mol Med. 2016 Dec;38(6):1661-1672
Sprague Dawley rats	Drug interaction model	Oral	20 mg/kg and 50 mg/kg	Single dose	Bergapten significantly increased the plasma exposure (AUC) and maximum concentration (Cmax) of tofacitinib and decreased clearance (CLz/F), indicating inhibition of tofacitinib metabolism in vivo	corylifolia on the pharmacokinetic profile of tofacitinib and the underlying mechanism. Front Pharmacol.
C57BL/6J mice	Escherichia coli-induced sepsis model	Intraperitoneal injection	50 mg/kg	24 hours and 1 hour before injection	Significantly ameliorated tissue inflammation and injury.	Acta Pharmacol Sin. 2023 Sep;44(9):1867-1878.
Mice	Castor oil-induced diarrhea model	Oral	50, 100, 200 mg/kg	Single dose, observed for 4 hours	Bergapten at doses of 50-200 mg/kg effectively reduced diarrheal secretions and intestinal secretions, showing antidiarrheal and antisecretory effects	Front Pharmacol. 2022 Nov 16;13:1005154.

{[proInfo.proName]}

CAS No.: 484-20-8

{[proInfo.proName]}

CAS No.: 484-20-8

Alternative Products

Product Details of Bergapten

Safety of Bergapten

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

NCT00533195	Atopic Dermatitis	Phase 3	Completed	-	Austria ... More >> Medical University of Vienna; University Clinic of Dermatology; Division of Special and Environmental Dermatology Vienna, Austria, 1090 Less <<
NCT00811005	Pustular Palmoplantar Psoriasi... More >>s Less <<	Phase 3	Unknown	October 2010	Austria ... More >> Medical University of Vienna; University Clinic of Dermatology; Division of Special and Environmental Dermatology Vienna, Austria, 1180 Less <<

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed